← All Twist Bioscience CORP filings

Twist Bioscience CORP Form 4 insider transactions

NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience COO Sells Shares to Cover Tax Obligations
Patrick John Finn, COO of Twist Bioscience, sold 492 shares of common stock on April 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations
William Banyai, a Senior Vice President at Twist Bioscience, sold 327 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience CEO Emily Leproust Reports Stock Sale to Cover Tax Obligations
Emily Leproust, CEO of Twist Bioscience, sold 1,132 shares of common stock on April 2, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations
Dennis Cho, a Senior Vice President at Twist Bioscience, sold shares to cover tax withholding obligations related to vesting Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience SVP of Human Resources, Paula Green, Sells Shares to Cover Tax Obligations
Paula Green, SVP of Human Resources at Twist Bioscience, sold 229 shares of common stock on April 2, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience Corp Executive Dennis Cho Sells Shares to Cover Tax Obligations
Dennis Cho, a Senior Vice President at Twist Bioscience Corp, sold 230 shares of common stock on March 20, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations
William Banyai, a Senior Vice President at Twist Bioscience, sold 442 shares of common stock on March 20, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience CEO Emily Leproust Reports Stock Sale to Cover Tax Obligations
Emily Leproust, CEO of Twist Bioscience, sold 1,128 shares of common stock on March 20, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience SVP of Human Resources, Paula Green, Sells Shares to Cover Tax Obligations
Paula Green, SVP of Human Resources at Twist Bioscience Corp, sold 200 shares of common stock on March 20, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations
Dennis Cho, a Senior Vice President at Twist Bioscience, sold shares to cover tax withholding obligations related to vesting Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations
Dennis Cho, a Twist Bioscience executive, sold 272 shares of common stock on March 6, 2024, to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations
Robert F. Werner, Chief Accounting Officer of Twist Bioscience, sold 181 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience CEO Emily Leproust Reports Stock Sale to Cover Tax Obligations
CEO Emily Leproust sold 1,487 shares of Twist Bioscience stock on March 6, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience SVP of Human Resources, Paula Green, Sells Shares to Cover Tax Obligations
Paula Green, SVP of Human Resources at Twist Bioscience, sold 600 shares of common stock on March 6, 2024, to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
TWST
Twist Bioscience CORP
Form 4: Twist Bioscience Executive Sells Shares to Cover Tax Obligations
William Banyai, a Senior Vice President at Twist Bioscience, sold 549 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.